Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

FEB 05, 2016 - Yahoo! News

A Must Read - Share

FDA reviewers support Celltrion's biosimilar Remicade

(Reuters) - U.S. Food and Drug Administration staff members on Friday said clinical data from Celltrion Inc's biosimilar form of blockbuster arthritis drug Remicade indicated it is "highly similar" to the branded product in terms of safety, purity and potency. FDA scientists released their supportive findings ahead of a scheduled meeting on Tuesday of an independent medical advisory panel to ...

Tags: FDA reviewers support Celltrion's biosimilar Remicade,  Pfizer Latest News

FEB 03, 2016 - Yahoo! News

A Must Read - Share

Pfizer, J&J, Merck evaluating technologies for Zika vaccine

(Reuters) - Pfizer Inc , Johnson and Johnson and Merck & Co Inc said they were evaluating their technologies or existing vaccines for their potential to combat Zika, a rapidly spreading mosquito-borne disease linked to birth defects. A number of drug developers and universities are attempting to produce a vaccine for Zika, which the World Health Organization (WHO) has declared ...

Tags: Pfizer, J&J, Merck evaluating technologies for Zika vaccine,  Pfizer Latest News

FEB 02, 2016 - Yahoo! News

A Must Read - Share

Pfizer 2016 forecast disappoints

U.S. drugmaker Pfizer Inc on Tuesday forecast 2016 revenue and earnings below analysts' estimates, largely because of the strong dollar. Pfizer, which plans to buy Botox maker Allergan Inc in the second half of this year, said it expected earnings of $2.20 to $2.30 per share in 2016. Tony Scherrer, director of research at Smead Capital Management, said Pfizer shares ...

Tags: Pfizer 2016 forecast disappoints,  Pfizer Latest News

FEB 02, 2016 - Yahoo! News

A Must Read - Share

Pfizer 2016 forecasts disappoint; shares fall

(Reuters) - U.S. drugmaker Pfizer Inc on Tuesday forecast 2016 revenue and earnings below analysts' estimates, largely because of the strong dollar. Pfizer, which plans to buy Botox maker Allergan Inc later this year in a $160 billion deal, said it expected earnings of $2.20 to $2.30 per share in 2016. Evercore ISI analyst Mark Schoenebaum said Pfizer attributed its ...

Tags: Pfizer 2016 forecasts disappoint; shares fall,  Pfizer Latest News

FEB 02, 2016 - Yahoo! News

A Must Read - Share

Pfizer forecasts 2016 revenue, earnings below estimates

(Reuters) - U.S. drugmaker Pfizer Inc , which is in the process of buying Botox-maker Allergan Plc for $160 billion, forecast 2016 revenue and earnings below analysts' estimates, citing generic competition and a strong dollar. The company said it expects reported revenue of $49 billion-$51 billion for the full year and adjusted earnings of $2.20-$2.30 per share. Analysts on average ...

Tags: Pfizer forecasts 2016 revenue, earnings below estimates,  Pfizer Latest News